ID
40858
Description
Study ID: 101468/902 Clinical Study ID: 101468/902 Study Title:A study to evaluate the effect of repeated oral doses of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and single oral doses of moxifloxacin (Bayer) as a positive control. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 5/26/20 5/26/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
May 26, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effect of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram (101468/902)
Similar models
PK Blood Sampling
- StudyEvent: ODM
C0178602 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
No comments